AUPH

Aurinia Pharmaceuticals Inc
9.51
0.00 (0.00%)
Stock Name Stock Symbol Market Stock Type
Aurinia Pharmaceuticals Inc AUPH NASDAQ Common Stock
  Price Change Price Change % Stock Price Last Trade
0.00 0.0% 9.51 19:00:00
Open Price Low Price High Price Close Price Previous Close
9.51
more quote information »

Recent News

Date Time Source Heading
13/3/202321:05EDGARCurrent Report Filing (8-k)
07/3/202308:30EDGARStatement of Changes in Beneficial Ownership (4)
07/3/202308:30EDGARStatement of Changes in Beneficial Ownership (4)
07/3/202308:30EDGARStatement of Changes in Beneficial Ownership (4)
07/3/202308:29EDGARStatement of Changes in Beneficial Ownership (4)
07/3/202308:29EDGARStatement of Changes in Beneficial Ownership (4)
07/3/202308:29EDGARStatement of Changes in Beneficial Ownership (4)
07/3/202308:29EDGARStatement of Changes in Beneficial Ownership (4)
07/3/202308:00BWAurinia Reports New Inducement Grants Under Nasdaq Listing..
28/2/202322:00BWAurinia Reports Fourth Quarter and Full Year 2022 Financial..
24/2/202322:00BWAurinia Pharmaceuticals to Present at Upcoming Investor..
08/2/202308:00BWAurinia Pharmaceuticals to Release Fourth Quarter and Full..
07/2/202308:00BWAurinia Reports New Inducement Grants Under Nasdaq Listing..
28/1/202308:10EDGARCurrent Report Filing (8-k)
26/1/202305:00BWAurinia Announces PTAB Has Terminated Inter Partes Review
25/1/202308:00BWAurinia Pharmaceuticals Announces Allowance of a New and..
21/1/202308:31EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
10/1/202308:11EDGARCurrent Report Filing (8-k)
07/1/202308:31EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
06/1/202322:00BWAurinia Provides Preliminary Unaudited Fourth Quarter and..
05/1/202308:05BWAurinia Pharmaceuticals to Present at Upcoming 41st Annual..
04/1/202308:55BWAurinia Reports New Inducement Grants Under Nasdaq Listing..
04/1/202301:12BWAurinia Announces LUPKYNIS® (voclosporin) Patent Challenge..
06/12/202208:05BWAurinia Reports New Inducement Grants Under Nasdaq Listing..
01/12/202208:05BWAurinia Announces the Great Britain Marketing Authorization..
24/11/202208:04EDGARStatement of Changes in Beneficial Ownership (4)
15/11/202208:50EDGARStatement of Changes in Beneficial Ownership (4)
10/11/202208:06EDGARStatement of Changes in Beneficial Ownership (4)
08/11/202200:45TRMNBloom Burton Remains a Buy on Aurinia Pharmaceuticals (AUPH)
07/11/202222:25TRMNH.C. Wainwright Sticks to Its Buy Rating for Aurinia..
03/11/202222:22TRMNAurinia Tanks After Low Patient Uptake for Lupkynis and..
03/11/202221:07EDGARCurrent Report Filing (8-k)
03/11/202221:00BWAurinia Reports Third Quarter and Nine Months 2022 Financial..
29/10/202208:30BWAurinia Pharmaceuticals to Release Third Quarter 2022..
29/10/202207:12EDGARStatement of Ownership (sc 13g)
28/10/202203:00BWAurinia Pharmaceuticals Announces Presentations at American..
27/10/202200:25TRMNAurinia Pharmaceuticals (AUPH) Receives a Buy from H.C...
21/10/202221:13EDGARCurrent Report Filing (8-k)
04/10/202207:05BWAurinia Reports New Inducement Grants Under Nasdaq Listing..
21/9/202206:05BWAurinia Pharmaceuticals Announces Presentations at American..
21/9/202201:25TRMNH.C. Wainwright Sticks to Its Buy Rating for Aurinia..
20/9/202206:51EDGARCurrent Report Filing (8-k)
20/9/202202:04DJNAurinia Pharmaceuticals: EC Approved Lupkynis for Active..
20/9/202201:15BWAurinia Announces European Commission Approval of LUPKYNIS®..
11/8/202213:15TRMNSVB Securities Keeps Their Buy Rating on Aurinia..
09/8/202220:36TRMNH.C. Wainwright Remains a Buy on Aurinia Pharmaceuticals..
04/8/202220:00BWAurinia Reports Second Quarter and Six Months 2022 Financial..
02/8/202206:14EDGARStatement of Changes in Beneficial Ownership (4)
02/8/202206:14EDGARStatement of Changes in Beneficial Ownership (4)
02/8/202206:05BWAurinia Reports New Inducement Grants Under Nasdaq Listing..
Your Recent History
NASDAQ
AUPH
Aurinia Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230320 09:05:09